This study is not yet accepting patients
An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Dates
- study startedcompletion around
- Principal Investigator
- by Stephen R. Marder (ucla)
Description
Summary
Details
Keywords
Eligibility
Lead Scientist at University of California Health
- Stephen R. Marder (ucla)
Dr. Stephen Marder holds the Dr. Daniel X. Freedman Administrative Chair in Academic Psychiatry.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, Los Angeles
- ID
- NCT05956600
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated